USP22 and neoplasm: Moreover, an injection of tumor cells (EG7, B16 and LLC-1) in mice with Usp22-deficient Tregs reduced tumor development through the downregulation of the Treg suppressive functions and their abundance in the TME, consequently enhancing the antitumor immune response.